AIMS: To determine sacral neuromodulation battery life and the patient and provider risk factors for early explantation in a population-based sample. METHODS: A 5% sample of Medicare beneficiaries from 1997 to 2007 served as the data source. All patients who had a sacral neuromodulation device implanted in that time period were included. Variables included in a multivariate analysis of risk factors for removal included gender, age, race, diagnosis, type of test phase, provider specialty, and volume. The number of device reprogramming events was also recorded in this time period. RESULTS: Mean follow-up was 60.5 months. Patients on average had 2.15 reprogramming episodes in their first year, with that number decreasing over subsequent years. Out of the 558 batteries implanted 63 (11.3%) were explanted. Of the 19 implanted individuals who carried the diagnosis of interstitial cystitis (IC), 11 (57.9%) had the battery removed. This was the only variable that predicted early removal, with an odds ratio of explantation of 10.5 (95% CI: 3.9-28.4). CONCLUSION: Very few sacral neuromodulation batteries, once implanted, are removed prematurely. Patients with IC, however, are at very high risk of requiring premature battery removal.
AIMS: To determine sacral neuromodulation battery life and the patient and provider risk factors for early explantation in a population-based sample. METHODS: A 5% sample of Medicare beneficiaries from 1997 to 2007 served as the data source. All patients who had a sacral neuromodulation device implanted in that time period were included. Variables included in a multivariate analysis of risk factors for removal included gender, age, race, diagnosis, type of test phase, provider specialty, and volume. The number of device reprogramming events was also recorded in this time period. RESULTS: Mean follow-up was 60.5 months. Patients on average had 2.15 reprogramming episodes in their first year, with that number decreasing over subsequent years. Out of the 558 batteries implanted 63 (11.3%) were explanted. Of the 19 implanted individuals who carried the diagnosis of interstitial cystitis (IC), 11 (57.9%) had the battery removed. This was the only variable that predicted early removal, with an odds ratio of explantation of 10.5 (95% CI: 3.9-28.4). CONCLUSION: Very few sacral neuromodulation batteries, once implanted, are removed prematurely. Patients with IC, however, are at very high risk of requiring premature battery removal.
Authors: A C van Voskuilen; D J A J Oerlemans; E H J Weil; R A de Bie; Ph E V A van Kerrebroeck Journal: Eur Urol Date: 2006-01-04 Impact factor: 20.096
Authors: S W Siegel; F Catanzaro; H E Dijkema; M M Elhilali; C J Fowler; J B Gajewski; M M Hassouna; R A Janknegt; U Jonas; P E van Kerrebroeck; A A Lycklama a Nijeholt; K A Oleson; R A Schmidt Journal: Urology Date: 2000-12-04 Impact factor: 2.649
Authors: R A Janknegt; M M Hassouna; S W Siegel; R A Schmidt; J B Gajewski; D A Rivas; M M Elhilali; D C Milam; P E van Kerrebroeck; H E Dijkema; A A Lycklama à Nÿeholt; M Fall; U Jonas; F Catanzaro; C J Fowler; K A Oleson Journal: Eur Urol Date: 2001-01 Impact factor: 20.096
Authors: Wesley M White; Joe D Mobley; Regula Doggweiler; Cindy Dobmeyer-Dittrich; Frederick A Klein Journal: Urology Date: 2009-02-04 Impact factor: 2.649
Authors: Camille P Vaughan; Alayne D Markland; Phillip P Smith; Kathryn L Burgio; George A Kuchel Journal: J Am Geriatr Soc Date: 2017-12-04 Impact factor: 5.562
Authors: Cindy L Amundsen; Yuko M Komesu; Christopher Chermansky; W Thomas Gregory; Deborah L Myers; Emily F Honeycutt; Sandip P Vasavada; John N Nguyen; Tracey S Wilson; Heidi S Harvie; Dennis Wallace Journal: Eur Urol Date: 2018-02-24 Impact factor: 20.096
Authors: Ranjana Jairam; Jamie Drossaerts; Tom Marcelissen; Gommert van Koeveringe; Desiree Vrijens; Philip van Kerrebroeck Journal: Urol Int Date: 2021-05-31 Impact factor: 1.934
Authors: Jose Carlos Truzzi; Cristiano Mendes Gomes; Carlos A Bezerra; Ivan Mauricio Plata; Jose Campos; Gustavo Luis Garrido; Fernando G Almeida; Marcio Augusto Averbeck; Alexandre Fornari; Anibal Salazar; Arturo Dell'Oro; Caio Cintra; Carlos Alberto Ricetto Sacomani; Juan Pablo Tapia; Eduardo Brambila; Emilio Miguel Longo; Flavio Trigo Rocha; Francisco Coutinho; Gabriel Favre; Jose Antonio Garcia; Juan Castano; Miguel Reyes; Rodrigo Eugenio Leyton; Ruiter Silva Ferreira; Sergio Duran; Vanda Lopez; Ricardo Reges Journal: Int Braz J Urol Date: 2016 Mar-Apr Impact factor: 1.541
Authors: Paul A Lehur; Michael Sørensen; Thomas C Dudding; Charles H Knowles; Stefan de Wachter; Stefan Engelberg; Klaus E Matzel Journal: Neuromodulation Date: 2020-03-09